Research interpretation
A PBM paper is not useful because it contains a wavelength and a dose. It is useful when you can reconstruct what light reached which tissue, how often, in whom, and what outcome changed. This guide gives you the checklist.
The minimum record
Record every wavelength, its bandwidth if reported, and whether the source is a laser, LED array, mask, panel, probe, or bed. A paper using a contact laser at 808 nm is not automatically transferable to a broad LED panel at 810 and 830 nm.
The source affects beam shape, coherence, contact, spot size, and uniformity. Coherence often matters less after light enters tissue, but geometry still determines where the energy goes.
Irradiance is optical power per area, usually mW/cm2. Ignore electrical wattage. Ask where and how irradiance was measured. A value at the device surface is not equivalent to the same number at six inches.
If a study omits irradiance, exposure time, or enough information to reconstruct dose, mark the protocol as incomplete. Do not fill the gap with a manufacturer headline.
J/cm² = mW/cm² × seconds ÷ 1,000
Example: 50 mW/cm² for 200 seconds equals 10 J/cm², before any adjustment for pulsing or duty cycle.
Check the paper’s math. Note whether the value is incident fluence at the skin, energy delivered to a probe area, or an estimate at a deeper target. Those are different claims.
Open the PBM dose calculatorDistance changes irradiance and coverage. Contact can reduce reflection and change tissue compression. A small spot delivers energy to a small area. A panel spreads energy over a much larger field. Record the treated area, the number of sites, and whether the operator moved the source.
A protocol that reports 10 J/cm2 at four one-centimeter spots is not the same intervention as 10 J/cm2 over the torso.
For pulsed studies, record frequency, pulse width, peak irradiance, average irradiance, and duty cycle. A paper may report peak power while dose is determined by average power. If duty cycle is missing, the protocol may not be reproducible.
Then record sessions per week, total sessions, timing relative to exercise or another treatment, and follow-up duration. The cumulative schedule often matters as much as one-session fluence.
Who was studied? Healthy adults, older adults, trained athletes, postoperative patients, and people with a diagnosed condition can respond differently. Record sample size, age, sex, skin type when relevant, inclusion criteria, baseline severity, medication restrictions, and dropout rate.
Then identify the primary outcome. Was it a validated clinical scale, laboratory marker, image analysis, self-report, performance test, or a post hoc subgroup? A statistically significant biomarker is not automatically a meaningful patient benefit.
Prefer randomized trials with a credible sham when the research question allows it. Check blinding, allocation, preregistration, missing data, confidence intervals, adverse events, and whether the paper corrected for multiple outcomes.
A small positive study can justify more research. It cannot establish that every device in the category works. Negative and null findings belong in the interpretation too.
Build a side-by-side record. Compare wavelength, irradiance at your intended distance, fluence, source geometry, treatment area, pulsing, and schedule. If a critical field is missing, label the translation uncertain. Do not assume that matching one dose number creates device equivalence.
Start from the manufacturer’s instructions and safety limits. A study protocol is evidence about the studied intervention, not a prescription for improvising with a different product.
Hale maintains the underlying global evidence artifact on the Canadian property. Use the PBM dose canonical table to inspect study-level records. This US guide explains how to interpret those records without duplicating the dataset.
A study can support a research conclusion without creating a cleared consumer indication. A device can be registered and listed without FDA reviewing it for safety or effectiveness. A cleared device has a specific record and intended use.
Verify device claims in the FDA database and read the Hale FDA documentation guide. The FDA explicitly states that registration and listing do not denote approval, clearance, or authorization in its consumer guidance.
Fluence is radiant energy delivered per unit area, usually expressed in joules per square centimeter. It is commonly calculated from irradiance and exposure time, but the reported value is only interpretable when measurement distance, treatment area, and device method are also clear.
Not safely from fluence alone. You also need the study wavelength, source type, beam or LED geometry, irradiance at the target, pulsing, contact, treated area, schedule, population, and endpoint. A consumer device may not reproduce those conditions.
No. Electrical wattage is power consumed by the device. Irradiance is optical power reaching a unit area at the measurement point. Panel wattage cannot substitute for a measured mW/cm² value.
No. Registration and listing do not denote approval, clearance, or authorization. When a device is cleared, the cleared intended use and device record still need to be checked. Regulatory status does not validate every protocol or marketing claim.